Axel Ullrich
E495345
Axel Ullrich is a pioneering German molecular biologist and cancer researcher known for his groundbreaking work in oncogenes and the development of targeted cancer therapies such as the drug Herceptin.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Axel Ullrich canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T5116856 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Axel Ullrich Context triple: [Otto Warburg Medal, notableRecipient, Axel Ullrich]
-
A.
Matthias Kleinheisterkamp
Matthias Kleinheisterkamp was a high-ranking Waffen-SS officer and division commander during World War II who served in several key SS formations on the Eastern and Western Fronts.
-
B.
Andreas Scholz
Andreas Scholz is a person known for bearing the surname Scholz, though no widely recognized public profile or specific notable achievements are clearly associated with him from the given information.
-
C.
Maximilian Scheffler
Maximilian Scheffler is a scientist known as a notable student and protégé of the German quantum chemist Joachim Sauer.
-
D.
Christoph Sauer
Christoph Sauer was an 18th-century German-American printer and publisher known for producing one of the earliest German-language Bibles in North America.
-
E.
Andreas Schmidt
Andreas Schmidt is a relatively common German personal name shared by multiple individuals across fields such as politics, sports, and the arts.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Axel Ullrich Target entity description: Axel Ullrich is a pioneering German molecular biologist and cancer researcher known for his groundbreaking work in oncogenes and the development of targeted cancer therapies such as the drug Herceptin.
-
A.
Matthias Kleinheisterkamp
Matthias Kleinheisterkamp was a high-ranking Waffen-SS officer and division commander during World War II who served in several key SS formations on the Eastern and Western Fronts.
-
B.
Andreas Scholz
Andreas Scholz is a person known for bearing the surname Scholz, though no widely recognized public profile or specific notable achievements are clearly associated with him from the given information.
-
C.
Maximilian Scheffler
Maximilian Scheffler is a scientist known as a notable student and protégé of the German quantum chemist Joachim Sauer.
-
D.
Christoph Sauer
Christoph Sauer was an 18th-century German-American printer and publisher known for producing one of the earliest German-language Bibles in North America.
-
E.
Andreas Schmidt
Andreas Schmidt is a relatively common German personal name shared by multiple individuals across fields such as politics, sports, and the arts.
- F. None of above. chosen
Statements (46)
| Predicate | Object |
|---|---|
| instanceOf |
German scientist
ⓘ
biochemist ⓘ cancer researcher ⓘ human ⓘ university teacher ⓘ |
| academicDegree | PhD in biochemistry ⓘ |
| awardReceived |
Lasker~DeBakey Clinical Medical Research Award
NERFINISHED
ⓘ
Robert Koch Prize NERFINISHED ⓘ Wolf Prize in Medicine NERFINISHED ⓘ |
| countryOfCitizenship | Germany ⓘ |
| dateOfBirth | 1943-10-19 ⓘ |
| educatedAt |
University of Heidelberg
NERFINISHED
ⓘ
University of Tübingen NERFINISHED ⓘ |
| employer |
Genentech
NERFINISHED
ⓘ
Max Planck Institute of Biochemistry NERFINISHED ⓘ |
| familyName | Ullrich NERFINISHED ⓘ |
| fieldOfWork |
biochemistry
ⓘ
cancer research ⓘ molecular biology ⓘ oncology ⓘ |
| givenName | Axel NERFINISHED ⓘ |
| hasPublicationType | highly cited researcher in oncology and molecular biology ⓘ |
| influenced | development of targeted cancer therapies against HER2-positive breast cancer ⓘ |
| knownFor |
cloning of the HER2/neu (ERBB2) oncogene
ⓘ
cloning of the human EGF receptor ⓘ contributions to the development of trastuzumab ⓘ development of targeted cancer therapies ⓘ research on oncogenes ⓘ work on receptor tyrosine kinases ⓘ |
| languageSpoken |
English
ⓘ
German ⓘ |
| memberOf |
European Molecular Biology Organization
NERFINISHED
ⓘ
German Academy of Sciences Leopoldina NERFINISHED ⓘ |
| name | Axel Ullrich NERFINISHED ⓘ |
| nationality | German ⓘ |
| notableStudent | Josef Penninger NERFINISHED ⓘ |
| notableWork |
contributions to the development of Herceptin (trastuzumab)
ⓘ
identification of oncogenic receptor tyrosine kinases ⓘ |
| placeOfBirth | Lauffen am Neckar NERFINISHED ⓘ |
| positionHeld |
director at Max Planck Institute of Biochemistry
ⓘ
staff scientist at Genentech ⓘ |
| researchInterest |
growth factor receptors
ⓘ
molecular mechanisms of cancer ⓘ signal transduction ⓘ |
| workLocation |
Martinsried
NERFINISHED
ⓘ
South San Francisco NERFINISHED ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Axel Ullrich Description of subject: Axel Ullrich is a pioneering German molecular biologist and cancer researcher known for his groundbreaking work in oncogenes and the development of targeted cancer therapies such as the drug Herceptin.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.